0.10Open0.10Pre Close13 Volume0 Open Interest7.00Strike Price125.00Turnover51.84%IV14.89%PremiumSep 20, 2024Expiry Date0.00Intrinsic Value100Multiplier27DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.2154Delta0.3361Gamma61.80Leverage Ratio-0.0049Theta0.0009Rho13.31Eff Leverage0.0049Vega
LifeStance Health Stock Discussion
TQ2 '24: Net loss: $23.3m Revenue: $312.3m, up 20% YoY Clinician base: Up 14% to 6,984 Visit volumes: Up 15% to 2m Adj. EBITDA: $28.6m, up 103% YoY '24 guidance: Rev. $1.2b-$1.242b, Center Margin $363m-$383m, Adj. EBITDA $90m-$100m.
No comment yet